This multi-faceted program aims to address clinical inertia amongst specialists when treating diabetes and giving them the guidance and confidence, based on real world evidence, to intensify treatment with GLP-1RAs when appropriate.

These independent medical education resources include a live webinar from Busan, Korea, in which leading experts from different regions will present case studies and discuss new and emerging GLP-1RAs usage. Coming soon are some expert-authored interactive patient case studies, which will put into practice real world data, in a format to test yourself with self-assessment questions. Lastly a freely downloadable Infographic booklet provides you with a set of key clinical decision making graphics, derived from the ADA/EASD Consensus Report published in Diabetologia journal, in an easy to read format.

Coming soon: Live webinar

Chaired by Melanie Davies, this interactive IME webinar will focus on treatment with GLP-1RAs, based on Real World data, and the emerging landscape of GLP-1RAs in the context of approved guidelines. Our international panel of experts will compare the efficacy and safety profiles of GLP-1RAs with SGLT2s and how to implement this knowledge to make the correct clinical decisions at the right time in localised healthcare settings.

Related content

Don’t miss out on this expert‑led webcast on the continuing evolution of glucagon‑like peptide‑1 receptor agonists, chaired by Professor John Wilding.

Scroll to Top